Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare ...

Signs of high cholesterol and diabetes can show up in the eyes, said the ophthalmologist. Here are the early warning signs to know.

Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging technology company developing healthcare solutions, and its Joint Venture ...

Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibitor, ...

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...

Screenings will be conducted at several pharmacies in the Greater Metropolitan Area to detect diabetic retinopathy ...

More than 170 people were screened for a condition known as diabetic eye disease through a free programme offered across the ...